Skip to content
Home
Careers with Us
Products
Member Center
Shop
Cart
Contact Us
Home
Careers with Us
Products
Member Center
Shop
Cart
Contact Us
฿
0.00
0
Cart
สมัครสมาชิก
เข้าสู่ระบบ
News
Lee’s Pharm was honoured with “2021 Top 100 Chinese Chemical Pharmaceutical Companies” Award
July 16, 2022
Zhaoke (Guangzhou) Oncology Pharmaceutical Ltd.had a very successful meeting with the reviewers from the Center for Drug Evaluation of NMPA of China
September 9, 2019
The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched
May 24, 2024
New product Teglutik® obtained Drug Registration Certificate
June 21, 2022
Azilsartan tablets obtained Drug Marketing Authorization
September 30, 2022
Provincial Center for ADR Monitoring visited Zhaoke-Hefei on assessment of pharmacovigilance system
June 2, 2023
Greater Pediatrics, Greater Kids, Greater China ——Ferplex of Lee’s Pharmaceutical Holdings Ltd. appeared in the 24th Congress of Chinese Pediatric Society
October 29, 2019
Lee’s Pharm has collaborated with Lok Sin Tong Community Pharmacy to donate a total of 900 boxes of masks
October 24, 2022
SillaJen and Lee’s Pharmaceutical Announce First Patient Enrolled in the PHOCUS Trial in ChinaPhase 3 Clinical Trial for Oncolytic Immunotherapy, Pexa-Vec, in Liver Cancer
September 6, 2018
Lee’s Pharm sponsored “The Healthcare and Biotech Road Map in Greater Bay Area” Symposium
September 9, 2022
Inclusion of Treprostinil Injection, Teglutik® and Trittico® in the National Reimbursement Drug List
January 19, 2023
The Group’s in-licensed product Adasuve® (Loxapine for Inhalation) obtained Drug Registration Certificate
December 4, 2023
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next
English
Thai
English
✕